# NSPA Advances USIL Registration

Luxembourg-based USIL Therapeutics passed the initial vendor registration assessment for NATO’s Support and Procurement Agency (NSPA), gaining access to its procurement platform and eligibility to participate in RFP processes. Full registration remains pending a Declaration of Eligibility from national authorities, and no NATO contract award has been reported. For procurement professionals, this is a supplier-eligibility development—not evidence of a contract award or a confirmed procurement opportunity for USIL.

- Companies pursuing NSPA work can distinguish initial assessment and platform access from completed registration; USIL’s full registration remains contingent on the Declaration of Eligibility.
- Contractors and suppliers should treat USIL as a prospective NSPA participant, not an awardee, and avoid assuming it has secured NATO-funded work.

**Jurisdictions:** international
**Industries:** Defense & Military, Healthcare
**Topics:** Regulatory Compliance
**Published:** November 20, 2026

### Government Entities
- NATO Support and Procurement Agency (NSPA)

### Vendors
- USIL Therapeutics (Prospective supplier; passed initial NSPA vendor registration assessment)

### Sources
- [USIL Therapeutics Passes NATO Vendor Registration Assessment | Wisevoter](https://wisevoter.com/world/2026/11/20/usil-therapeutics-passes-nato-vendor-assessment) - Wisevoter